Collecting this data requires a comprehensive IoT platform—but is that its only role? Or can it offer even more?
"The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...
The JLens 500 Jewish Advocacy U.S. ETF launched late last month and has already amassed more than $100 million in assets.
Human activity has made normal climate change abnormal. In our quest to expand and modernize our living conditions, we ...
Explore how Microsoft's five plays for accelerating sustainability with AI can help your business advance resilience, ...